Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) announces a share repurchase program. Under the program, the company will repurchase up to CNY 120 million. The shares will be purchased at a price not exceeding CNY 12 per share.

The purpose of the program is to use the repurchased shares for equity incentive or employee shareholding plan. If the company fails to use the repurchased shares for the above purpose within 3 years of completion of the program, the unused shares will be cancelled. The program will be funded from company's own funds.

The program will be valid for 6 months.